NANS led efforts on behalf of the Multi Society Pain Workgroup to object to insurers’ classification of closed-loop spinal cord stimulation (SCS) as experimental, investigational and/or unproven. Cigna and EviCore revised their policies to include coverage of closed-loop SCS.